以质量求发展，以服务铸品牌

护理学报 ›› 2024, Vol. 31 ›› Issue (18): 39-44.doi: 10.16460/j.issn1008-9969.2024.18.039

• 循证护理 • 上一篇    下一篇

胆汁淤积患者皮肤瘙痒管理的最佳证据总结

曹春菊1a, 王文1b, 黄梅英1c, 韩冰1c, 曾梅1c, 罗文洁1c, 张小琴2, 黄炜铃1c, 李文英1c, 苏韵涛1c, 唐素娟1c   

  1. 1.广州医科大学附属清远医院（清远市人民医院）a.护理部;b.普外二区;c.普外一区;广东 清远 511518;
    2.清远职业技术学院,广东 清远 511510
  • 收稿日期:2024-04-11 出版日期:2024-09-25 发布日期:2024-10-08
  • 作者简介:曹春菊（1981-）,女,湖南永州人,硕士研究生,主任护师,硕士研究生导师,护理部副主任。
  • 基金资助:
    2022年广州医科大学附属清远医院（清远市人民医院）专项基金（QYRYCRC2023004）; 2021广东省教育科学规划课题（2021GXJK695）

Best evidence summary for management of pruritus in patients with cholestasis

CAO Chun-ju1a, WANG Wen1b, HUANG Mei-ying1c, HAN Bing1c, ZENG Mei1c, LUO Wen-jie1c, ZHANG Xiao-qin2, HUANG Wei-ling1c, LI Wen-ying1c, SU Yun-tao1c, TANG Su-juan1c   

  1. 1a. Dept. of Nursing Administration; 1b. Dept. of General Surgery II; 1c Dept. of General Surgery I, Affiliated Qingyuan Hospital (Qingyuan People’s Hospital), Guangzhou Medical University, Qingyuan 511518, China;
    2. Qingyuan Polytechnic, Qingyuan 511510, China
  • Received:2024-04-11 Online:2024-09-25 Published:2024-10-08

PDF (PC)

159

赞

摘要： 目的 评价并整合胆汁淤积患者皮肤瘙痒管理的相关证据,为胆汁淤积所致皮肤瘙痒患者的临床护理实践提供参考依据。方法 针对胆汁淤积患者皮肤瘙痒问题,进行国内外证据检索,包括临床决策、指南、专家共识、证据总结、系统评价。2名具有循证医学专业背景的研究者对文献质量进行独立评价和证据级别评定,并提取相关证据。结果 共纳入文献18篇,包括4篇临床决策、2篇指南、2篇证据总结、6篇系统评价和4篇专家共识,总结归纳出瘙痒评估、瘙痒病因处理、皮肤护理、局部治疗、全身用药、手术治疗、辅助治疗、心理护理8个方面,共23条最佳证据,形成了胆汁淤积患者皮肤瘙痒管理方案。结论 医护人员在临床实践中可结合目前最佳证据和患者价值观,制定个性化的治疗计划,以提高患者生活质量。

关键词: 胆汁淤积, 皮肤瘙痒, 循证护理

Abstract: Objective To evaluate and summarize the best evidence for the management of pruritus in patients with cholestasis, and to provide reference for clinical nursing practice in the treatment of pruritus caused by cholestasis. Methods An evidence-based nursing approach and the "5S" evidence model were employed to search for relevant evidence on the management of pruritus in cholestatic patients, including clinical decision-making, guidelines, expert consensus, evidence summaries, and systematic reviews from both domestic and international sources. Two researchers with background in evidence-based medicine independently assessed the quality of the literature and rated the evidence level, extracting the evidence meeting the criteria. Results A total of 18 articles were collected, including 4 clinical decision-makings, 2 guidelines, 2 evidence summaries, 6 systematic reviews, and 4 expert consensuses. Twenty-three pieces of best evidence were summarized into eight areas: pruritus assessment, management of pruritus etiology, skin care, topical treatments, systemic medications, surgical treatments, adjunctive therapies, and psychological interventions. A management protocol for pruritus in cholestatic patients was developed. Conclusion In clinical practice, healthcare professionals should consider patient conditions and preferences to develop personalized treatment plans so as to improve the quality of life for patients.

Key words: cholestasis, pruritus, evidence-based nursing

中图分类号: 

  • R473.57
[1] Wu H,Chen C,Ziani S,et al.Fibrotic events in the progression of cholestatic liver disease[J]. Cells,2021, 10(5):1107.DOI: 10.3390/cells10051107.
[2] Murray-Brown FL.Naltrexone for cholestatic itch: a systematic review[J]. BMJ Support Palliat Care,2021,11(2): 217-225.DOI: 10.1136/bmjspcare-2020-002801.
[3] Langedijk J, Beuers UH,Oude Elferink RPJ,et al.Cholestasis-associated pruritus and its pruritogens[J]. Front Med (Lausanne),2021(8): 639674.DOI: 10.3389/fmed.
[4] Mittal A.Cholestatic itch management[J]. Curr Probl Dermatol,2016(50): 142-148.DOI: 10.1159/000446057.
[5] Beuers U, Wolters F,Oude Elferink RPJ,et al.Mechanisms of pruritus in cholestasis: understanding and treating the itch[J]. Nat Rev Gastroenterol Hepatol,2023,20(1): 26-36.DOI: 10.1038/s41575-022-00687-7.
[6] Decock S, Roelandts R,Steenbergen WV,et al.Cholestasis-induced pruritus treated with ultraviolet B phototherapy: an observational case series study[J]. J Hepatol, 2012,57(1): 637-641.DOI: 10.1016/j.jhep.2012.04.023.
[7] Trivella J,Levy C.Safety considerations for the management of cholestatic itch[J]. Expert Opin Drug Saf,2021,20(8):915-924. DOI: 10.1080/14740338.2021.1915984.
[8] 许妮娜,杨中善,刘宁,等.神经外科患者规范化身体约束管理的循证护理实践[J].护理学报,2020,27(19):41-46.DOI:10.16460/j.issn1008-9969.2020.19.041.
[9] Alper BS, Haynes RB.EBHC pyramid 5.0 for accessing preappraised evidence and guidance[J]. Evid Based Med,2016,21(4): 123-125.DOI: 10.1136/ebmed-2016-110447.
[10] Hoffmann-Eβer W, Siering U, Neugebauer EAM, et al.Guideline appraisal with AGREE II: online survey of the potential influence of AGREE II items on overall assessment of guideline quality and recommendation for use[J]. BMC Health Serv Res, 2018,18(1):143.DOI:10.1186/s12913-018-2954-8.
[11] Foster MJ,Shurtz S.Making the Critical Appraisal for Summaries of Evidence (CASE) for evidence-based medicine (EBM): critical appraisal of summaries of evidence[J]. J Med Libr Assoc,2013,101(3):192-198. DOI:10.3163/1536-5050.101.3.008.
[12] Buccheri RK,Sharifi C.Critical appraisal tools and reporting guidelines for evidence-based practice[J]. Worldviews Evid Based Nurs,2017, 14(6):463-472. DOI: 10.1111/wvn.12258.
[13] 王春青,胡雁.JBI证据预分级及证据推荐级别系统(2014版)[J].护士进修杂志,2015,30(11):964-967.DOI:10.16821/j.cnki.hsjx.2015.11.002.
[14] 林穗仪,何家欣,纪翠红,等.胆管癌患者光动力治疗避光管理的最佳证据总结[J].护理学报,2022,29(23):39-44.DOI:10.16460/j.issn1008-9969.2022.23.039.
[15] Raoul P, Sanjiv C.Pruritus associated with cholestasis[EB/OL].(2023-03-03)[2024-07-01].https://www.uptodate.cn/.
[16] Shalini D.Overview of pruritus in palliative care[J]. [EB/OL].(2023-07-13)[2024-07-01].https://www.uptodate.cn/.
[17] Sara BF, Gil Y. Etiology and patient evaluation[EB/OL].(2024-07)[2024-08-09].https://www.uptodate.cn/.
[18] Sara BF, Gil Y.Pruritus: therapies for generalized pruritus. [EB/OL].(2022-01-20)[2024-07-01].https://www.uptodate.cn/.
[19] Whitehorn A. Cholestasis: pruritus (itch) management. [EB/OL].(2021-09-27)[2021-08-18].https://jbi.global/Pruritus- (Itch) -Management.
[20] The Joanna Briggs Institute(JBI). Pruritus in cholestasis: management[EB/OL].(2021-08-18)[2021-09-24].https:/jbiglobal/Pruritus-Cholestasis-Management.
[21] Millington GWM,Collins A,Lovell CR,et al.British Association of Dermatologists’ guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis,2018[J]. Br J Dermatol,2018,178(1): 34-60. DOI: 10.1111/bjd.16117.
[22] 中华医学会肝病学分会.胆汁淤积性肝病管理指南(2021)[J]. 中华肝脏病杂志,2022,30(3):253-263.DOI:10.3760/cma.j.cn112138-20211112-00795.
[23] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会. 胆汁淤积性肝病诊断和治疗共识(2015)[J]. 中华消化杂志, 2015, 35(12):799-810.DOI:10.3760/cma.j.issn.0254-1432.2015.12.002.
[24] 曹建彪,陈永平,成军,等. 胆汁淤积性肝病诊断治疗专家共识:2015年更新[J]. 中国肝脏病杂志(电子版),2015(2):1-11. DOI:10.3969/j.issn.1674-7380.2015.02.001.
[25] 国家感染性疾病临床医学研究中心. 肝内胆汁淤积症诊治专家共识(2021版)[J]. 中华临床感染病杂志,2021,14(6):401-412.DOI:10.3760/cma.j.issn.1674-2397.2021.06.001.
[26] 李元文,李楠.皮肤瘙痒症中医治疗专家共识[J].中国中西医结合皮肤性病学杂志,2017, 16(2):189-190.DOI:10.3969/j.issn.1672-0709.2017.02.036.
[27] Jin XY, Khan TM.Quality of life among patients suffering from cholestatic liver disease-induced pruritus: a systematic review[J]. J Formos Med Assoc,2016,115(9):689-702. DOI: 10.1016/j.jfma.2016.05.006.
[28] Dervout C, Boulais N,Barnetche T,et al. Efficacy of treatments for cholestatic pruritus: a systemic review and Meta-analysis[J]. Acta Derm Venereol, 2022(102):adv00653. DOI: 10.2340/actadv.v102.310.
[29] Shen N, Pan J,Miao H,et al.Fibrates for the treatment of pruritus in primary biliary cholangitis: a systematic review and Meta-analysis[J]. Ann Palliat Med,2021,10(7):7697-7705. DOI: 10.21037/apm-21-1304.
[30] Pongcharoen P,Fleischer AB Jr.An evidence-based review of systemic treatments for itch[J]. Eur J Pain, 2016,20(1):24-31. DOI: 10.1002/ejp.766.
[31] Patel SP,Vasavda C,Ho B,Meixiong J,et al.Cholestatic pruritus: emerging mechanisms and therapeutics[J]. J Am Acad Dermatol,2019,81(6):1371-1378. DOI: 10.1016/j.jaad.2019.04.035.
[32] Medina-Morales E,Barba Bernal R,Gerger H,et al.Pharmacological therapy of pruritus in primary biliary cholangitis: a systematic review and Meta-analysis of randomized clinical trials[J]. J Clin Gastroenterol,2023, 57(2):143-152. DOI: 10.1097/MCG.0000000000001797.
[33] 王曼,孙凤霞. 胆汁淤积性肝病并发皮肤瘙痒的发病机制及治疗进展[J]. 临床肝胆病杂志,2014(11):1208-1211. DOI:10.3969/j.issn.1001-5256.2014.11.031.
[1] 张静, 彭焕椽, 陈佳, 鲁永锦, 刘克玄, 侯晓敏. 成人体外循环心脏手术患者预防手术部位感染的最佳证据总结[J]. 护理学报, 2025, 32(4): 41-47.
[2] 李若雨, 刘鑫, 林萍, 陈丹, 林桦. 出院患者用药安全管理的最佳证据总结[J]. 护理学报, 2025, 32(3): 50-55.
[3] 杨小娟, 毛孝容, 王静, 江华, 李蓉, 樊宇, 文青, 李林章, 陈晓容. 成人重度烧伤患者早期肠内营养管理的最佳证据总结[J]. 护理学报, 2025, 32(3): 56-61.
[4] 刘硕怡, 熊莉娟, 李凌, 王玉梅, 何嘉, 李鑫, 袁淑蕾, 郭雪琴, 王暘婧, 张慧娟. 老年住院患者衰弱预防及管理临床实践指南的质量评价及内容分析[J]. 护理学报, 2025, 32(2): 50-55.
[5] 闫亚铃, 乐美妮, 姚桃琴, 王雪莲, 姜建玲, 辛艺. 老年胃肠肿瘤患者围手术期衰弱管理方案的构建[J]. 护理学报, 2025, 32(2): 74-78.
[6] 陈洁, 孟庆童, 刘惊今, 吴艳妮. 基于指南的慢性心力衰竭患者运动康复科普手册研制[J]. 护理学报, 2024, 31(9): 36-41.
[7] 符路路, 解艺璇, 王玥, 魏巍, 张传英, 朱宇. 新生儿操作性疼痛听觉刺激干预的证据总结[J]. 护理学报, 2024, 31(9): 42-47.
[8] 纪锐婷, 林丹娜, 刘小成, 李婷婷, 谢映梅, 胡冰, 应文娟. 早产儿初乳口腔免疫疗法的最佳证据总结[J]. 护理学报, 2024, 31(8): 37-42.
[9] 张小莉, 杨鑫玉, 肖宇, 刘春燕, 张璐, 伍晓琴, 黄月霖, 傅静. 晚期癌症患者代理决策者安宁疗护决策后悔研究的范围综述[J]. 护理学报, 2024, 31(8): 49-54.
[10] 周毅峰, 杨继平, 胡正中, 袁浩. 肝癌切除手术患者目标导向性血糖监测的证据总结[J]. 护理学报, 2024, 31(7): 46-50.
[11] 莫选菊, 吴远, 张曼, 刘章来, 申铁梅. 共患慢性失眠症住院患者实施睡眠限制疗法的证据总结[J]. 护理学报, 2024, 31(6): 62-66.
[12] 杨建国, 何细飞, 鄢建军, 张梦, 杨纯子, 徐蓉, 王艳芳. 局部枸橼酸抗凝在连续性肾脏替代治疗中的应用及管理的最佳证据总结[J]. 护理学报, 2024, 31(4): 48-53.
[13] 刘璇, 蓝玉清, 李梦如, 王小惠, 钟雪梅, 周文. 住院老年性痴呆患者跌倒预防的最佳证据总结[J]. 护理学报, 2024, 31(4): 54-59.
[14] 祁水林, 林桦, 邓锐颖, 李荣杰, 李若雨, 王凤廷. 老年皮肤瘙痒症患者非药物管理的最佳证据总结[J]. 护理学报, 2024, 31(3): 46-50.
[15] 杨丽娜, 黄蓉, 姚梅琦, 王竹青, 徐怡婷, 谢佩敏. 产后母乳喂养行为中断风险预测模型的系统评价[J]. 护理学报, 2024, 31(23): 59-65.
Viewed
Full text


Abstract

Cited
  Shared   
No Suggested Reading articles found!